Skip to main content
Clinical Trials/KCT0005304
KCT0005304
Not Yet Recruiting
N/A

Multicenter prospective cohort study on the development of benign gallbladder disease and molecular analysis of bile composition in non-alcoholic fatty liver disease

Hanyang University Seoul Hospital0 sites780 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Hanyang University Seoul Hospital
Enrollment
780
Status
Not Yet Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Observational Study
Sex
All

Investigators

Sponsor
Hanyang University Seoul Hospital

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients hospitalized for cholecystectomy due to a benign disease of the gallbladder (gallstone or gallbladder polyp)
  • 2\. 19 to 80

Exclusion Criteria

  • 1\. For acute cholecystitis, grade II \& III of Tokyo guideline 2018
  • 2\. In case of acute cholecystitis, hepatitis level is more than 5 times the upper limit of normal.
  • 3\. When jaundice level is more than 3 times the normal upper limit due to acute inflammation
  • 4\. If there is a tendency to hemorrhage due to prothrombin time less than 50,000 prolonged 1\.5 times or more
  • 5\. In the past 2 years, alcoholic liver disease is suspected with a weekly alcohol consumption of 210g or more in men and 140g or more in women.
  • 6\. A case of liver disease caused by chronic hepatitis B or C
  • 7\. If you have a history of taking medications that can cause fatty liver
  • A. Glucocorticoid
  • B. Tamoxifen
  • C. Methotrexate

Outcomes

Primary Outcomes

Not specified

Similar Trials